title: Intravesical therapy.
abstract: Intravesical therapy is given as an adjunct to transurethral resection of superficial bladder tumors to eradicate existing disease, inhibit tumor recurrence, and prevent progression to muscle invasion or metastasis. Of the available agents, bacillus Calmette-Guerin (BCG) fulfills these goals and appears superior to chemotherapeutic drugs.
authors.affiliation: Department of Surgery, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New York, New York.
authors.forename: H W
authors.initials: HW
authors.lastname: Herr
mesh_terms: D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002278:Carcinoma in Situ / Q000188:drug therapy* / Q000601:surgery; D002291:Carcinoma, Papillary / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents